Positive Results on Anifrolumab for Lupus Published in New England Journal of Medicine
December 18, 2019
The Lupus Research Alliance (LRA) welcomes additional positive results published today in the New England Journal of...
anifrolumab
Breadth of Clinical Research Presented at the 2019 ACR/ARP Annual Meeting Brings Hope for New Lupus Treatments
November 14, 2019
The Lupus Research Alliance staff was on the ground at the 2019 ACR/ARP Annual Meeting and highly...
Lupus Research Alliance Response to Positive Data from Phase 3 Anifrolumab Trial Presented at 2019 ACR/ARP Annual Meeting
NEW YORK, NY – November 11. The Lupus Research Alliance (LRA) congratulates AstraZeneca on new positive results from the...
LRA Applauds Exciting Lupus Research Being Presented at 2019 ACR/ARP Annual Meeting
Includes 16 presentations of studies funded by the Lupus Research Alliance on a variety of immune pathways
Results...
MOMENTOUS NEWS — Potential New Lupus Treatment Effectively Reduced Disease Activity in Phase III Trial
NEW YORK, NY. August 29 -- The Lupus Research Alliance is excited to share the good news that a...
ACR|ARHP News on Potential New Lupus Treatments
October 25, 2018
The Lupus Research Alliance was on the ground at the American College of Rheumatology 2018 meeting to...